Pleural Diffusion of Voriconazole in a Patient with Aspergillus fumigatus Empyema Thoracis
Author(s) -
JeanBaptiste Stern,
Philippe Girard,
Raffaele Caliandro
Publication year - 2004
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.48.3.1065.2004
Subject(s) - voriconazole , aspergillus fumigatus , empyema , medicine , aspergillosis , aspergillus , microbiology and biotechnology , surgery , biology , antifungal , dermatology , immunology
Fungal empyema is an emerging clinical entity associated with a high mortality rate ([1][1]). We describe a case of a patient with empyema thoracis due to Aspergillus fumigatus successfully treated by chest tube drainage associated with voriconazole (VZ). Pleural concentrations of VZ demonstrated
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom